Celecoxib (Celebrex) is Safe for Breastfeeding
Celecoxib is compatible with breastfeeding and you can continue nursing without interruption. The relative dose that infants receive through breast milk is very low, and breastfeeding may continue as normal 1.
Evidence Supporting Safety
Guideline Recommendations
The 2020 Association of Anaesthetists guideline explicitly states that "the relative dose that infants are exposed to via milk is very low, and breastfeeding may continue" when mothers take celecoxib 1. This guideline places celecoxib among NSAIDs that are compatible with breastfeeding, alongside ibuprofen, diclofenac, naproxen, ketorolac, and parecoxib.
FDA Drug Label Information
The FDA label for Celebrex provides reassuring data: limited data from 3 published reports including 12 breastfeeding women showed low levels in breast milk, with calculated average daily infant dose of 10-40 mcg/kg/day—less than 1% of the weight-based therapeutic dose for a two-year-old child 2. Two breastfed infants (ages 17 and 22 months) showed no adverse events. The label advises that "caution should be exercised," which is standard conservative language, but the data support safety.
Research Evidence
Multiple pharmacokinetic studies confirm minimal infant exposure:
- The milk-to-plasma ratio averages 0.18-0.23, meaning very little drug transfers into breast milk 3, 4
- The relative infant dose is approximately 0.23-0.30% of the maternal weight-adjusted dose—well below the 10% threshold generally considered safe 3, 4
- Average milk concentrations are 66 mcg/L, resulting in negligible infant exposure 3
- Elimination half-life in milk is 4.0-6.5 hours, allowing for rapid clearance 5
Clinical Context
Celecoxib offers advantages over some other NSAIDs during breastfeeding:
- Better gastrointestinal safety profile compared to non-selective NSAIDs, which is relevant for maternal health 6
- Minimal transfer to breast milk due to its pharmacokinetic properties (high protein binding, molecular characteristics)
- No documented adverse effects in breastfed infants in published case reports 2, 3
Important Caveats
While celecoxib is safe for breastfeeding:
- Use the lowest effective dose for the shortest duration needed, as with all medications during lactation
- Monitor your infant for any unusual symptoms (though none have been reported in the literature)
- Consider alternative NSAIDs like ibuprofen if you prefer options with even more extensive lactation safety data, though celecoxib's evidence is robust
- The safety data primarily comes from short-term use; long-term continuous use during breastfeeding has less documentation
Bottom Line
You can safely take celecoxib while breastfeeding based on both guideline recommendations and pharmacokinetic data showing minimal infant exposure. The infant receives less than 1% of a therapeutic pediatric dose through breast milk, and no adverse effects have been documented in nursing infants.